Advertisement
Screener

BioCrude Technologies USA, Inc. Diluted Shares Outstanding (Weighted Average)

BioCrude Technologies USA, Inc. Diluted Shares Outstanding (Weighted Average)

BioCrude Technologies USA, Inc. reported Diluted Shares Outstanding (Weighted Average) of 50.87 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-11

  • BioCrude Technologies USA, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 50.87M shares, a 0.14% increase year-over-year.
  • BioCrude Technologies USA, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 50.76M shares, a 0.07% decline year-over-year.
  • BioCrude Technologies USA, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 50.56M shares, a 0.96% decline year-over-year.
  • BioCrude Technologies USA, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 50.80M shares, a 0.00% increase year-over-year.
  • BioCrude Technologies USA, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 50.74M shares, a 0.24% decline from fiscal 2024.
  • BioCrude Technologies USA, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 50.86M shares, a 0.15% increase from fiscal 2023.
  • BioCrude Technologies USA, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 50.78M shares, a 0.10% increase from fiscal 2022.
  • BioCrude Technologies USA, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 50.73M shares.
Period endWeighted Average Number of Shares Outstanding, Diluted 3 monthWeighted Average Number of Shares Outstanding, Diluted 6 monthWeighted Average Number of Shares Outstanding, Diluted 9 monthWeighted Average Number of Shares Outstanding, Diluted 12 month
2026-06-3050.87M shares
10-Q · filed 2026-08-11
50.87M shares
10-Q · filed 2026-08-11
50.73M shares
derived: average of 3 quarters · filed 2026-08-11
50.75M shares
derived: average of 4 quarters · filed 2026-08-11
2026-03-3150.76M shares
10-Q · filed 2026-05-13
50.66M shares
derived: average of 2 quarters · filed 2026-05-13
50.71M shares
derived: average of 3 quarters · filed 2026-05-13
50.73M shares
derived: average of 4 quarters · filed 2026-08-11
2025-12-3150.56M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
50.68M shares
derived: average of 2 quarters · filed 2026-03-27
50.72M shares
derived: average of 3 quarters · filed 2026-08-11
50.74M shares
10-K · filed 2026-03-27
2025-09-3050.80M shares
10-Q · filed 2025-11-12
50.80M shares
derived: average of 2 quarters · filed 2026-08-11
50.80M shares
10-Q · filed 2025-11-12
50.86M shares
derived: average of 4 quarters · filed 2026-08-11
2025-06-3050.80M shares
10-Q · filed 2026-08-11
50.80M shares
10-Q · filed 2026-08-11
50.88M shares
derived: average of 3 quarters · filed 2026-08-11
50.86M shares
derived: average of 4 quarters · filed 2026-08-11
2025-03-3150.80M shares
10-Q · filed 2026-05-13
50.92M shares
derived: average of 2 quarters · filed 2026-05-13
50.88M shares
derived: average of 3 quarters · filed 2026-05-13
50.86M shares
derived: average of 4 quarters · filed 2026-05-13
2024-12-3151.05M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
50.92M shares
derived: average of 2 quarters · filed 2026-03-27
50.88M shares
derived: average of 3 quarters · filed 2026-03-27
50.86M shares
10-K · filed 2026-03-27
2024-09-3050.80M shares
10-Q · filed 2025-11-12
50.80M shares
derived: average of 2 quarters · filed 2025-11-12
50.80M shares
10-Q · filed 2025-11-12
50.79M shares
derived: average of 4 quarters · filed 2025-11-12
2024-06-3050.80M shares
10-Q · filed 2025-08-13
50.80M shares
10-Q · filed 2025-08-13
50.79M shares
derived: average of 3 quarters · filed 2025-08-13
50.79M shares
derived: average of 4 quarters · filed 2025-08-13
2024-03-3150.80M shares
10-Q · filed 2025-05-14
50.79M shares
derived: average of 2 quarters · filed 2025-05-14
50.79M shares
derived: average of 3 quarters · filed 2025-05-14
50.78M shares
derived: average of 4 quarters · filed 2025-05-14
2023-12-3150.79M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
50.78M shares
derived: average of 2 quarters · filed 2025-03-27
50.78M shares
derived: average of 3 quarters · filed 2025-03-27
50.78M shares
10-K · filed 2025-03-27
2023-09-3050.78M shares
10-Q · filed 2024-11-07
50.77M shares
derived: average of 2 quarters · filed 2024-11-07
50.78M shares
10-Q · filed 2024-11-07
50.77M shares
derived: average of 4 quarters · filed 2024-11-07
2023-06-3050.76M shares
10-Q · filed 2024-08-09
50.76M shares
10-Q · filed 2024-08-09
50.76M shares
derived: average of 3 quarters · filed 2024-08-09
50.75M shares
derived: average of 4 quarters · filed 2024-08-09
2023-03-3150.75M shares
10-Q · filed 2024-05-08
50.76M shares
derived: average of 2 quarters · filed 2024-05-08
50.74M shares
derived: average of 3 quarters · filed 2024-05-08
2022-12-3150.77M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
50.74M shares
derived: average of 2 quarters · filed 2024-03-27
50.73M shares
10-K · filed 2024-03-27
2022-09-3050.72M shares
10-Q · filed 2023-11-13
50.72M shares
10-Q · filed 2023-11-13